- Home
- MTZ vs NBIX Comparison
MTZ vs NBIX Comparison
Compare MTZ & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTZ | NBIX |
|---|---|---|
| Founded | 1929 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Water Sewer Pipeline Comm & Power Line Construction | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4B | 15.2B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | MTZ | NBIX |
|---|---|---|
| Price | $235.86 | $139.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 20 | 21 |
| Target Price | ★ $231.37 | $177.29 |
| AVG Volume (30 Days) | 869.5K | ★ 1.0M |
| Earning Date | 02-26-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 270.77 | 12.44 |
| EPS | ★ 4.20 | 4.19 |
| Revenue | ★ $13,762,473,000.00 | $2,682,700,000.00 |
| Revenue This Year | $15.48 | $23.68 |
| Revenue Next Year | $10.21 | $18.47 |
| P/E Ratio | $56.16 | ★ $33.55 |
| Revenue Growth | 12.99 | ★ 19.61 |
| 52 Week Low | $99.70 | $84.23 |
| 52 Week High | $237.76 | $160.18 |
Technical Indicators
Market Signals| Indicator | MTZ | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 59.00 | 39.13 |
| Support Level | $222.51 | $134.03 |
| Resistance Level | $237.38 | $142.16 |
| Average True Range (ATR) | 5.86 | 2.85 |
| MACD | 0.71 | -0.94 |
| Stochastic Oscillator | 71.08 | 28.22 |
Price Performance
Historical ComparisonAbout MTZ MasTec Inc.
MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. Its primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; oil and gas; power delivery; and other.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.